Literature DB >> 7824726

Uneven fatty replacement of the pancreas: evaluation with CT.

S Matsumoto1, H Mori, H Miyake, H Takaki, T Maeda, Y Yamada, M Oga.   

Abstract

PURPOSE: To determine the computed tomographic (CT) features of uneven fatty replacement of the pancreas and clarify their radiologic and clinical importance.
MATERIALS AND METHODS: CT scans from 80 patients with uneven fatty replacement of the pancreas were reviewed. Uneven fatty replacement of the pancreas was classified into two types. In type 1, the posterior aspect of the head of the pancreas was spared from intense fatty replacement. In type 2, the focal area around the common bile duct (CBD) was spared from fatty replacement. Each type was divided into two subgroups on the basis of whether the body and tail of the pancreas showed intense fatty replacement (type a = negative for intense fatty replacement, type b = positive for intense fatty replacement). Findings from endoscopic retrograde cholangiopancreatography performed in five patients, histopathologic examination in one patient, and clinical examination in all 80 patients were also evaluated.
RESULTS: Twenty-eight patients (35%) had type 1a replacement, 29 (36%) had type 1b replacement, nine (11%) had type 2a replacement, and 14 (18%) had type 2b replacement. In all patients, the anterior aspect of the head of the pancreas showed distinctly lower attenuation at CT.
CONCLUSION: Fatty replacement is more severe in the anterior aspect of the head of the pancreas. The posterior aspect of the head of the pancreas and the area around the CBD tended to be spared.

Entities:  

Mesh:

Year:  1995        PMID: 7824726     DOI: 10.1148/radiology.194.2.7824726

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  37 in total

Review 1.  Invisible fat on CT: making it visible by MRI.

Authors:  Emre Ünal; Ali Devrim Karaosmanoğlu; Deniz Akata; Mustafa Nasuh Özmen; Muşturay Karçaaltıncaba
Journal:  Diagn Interv Radiol       Date:  2016 Mar-Apr       Impact factor: 2.630

2.  Development of pancreatic cancer is predictable well in advance using contrast-enhanced CT: a case-cohort study.

Authors:  Wataru Gonoi; Takana Yamakawa Hayashi; Hidemi Okuma; Masaaki Akahane; Yousuke Nakai; Suguru Mizuno; Ryosuke Tateishi; Hiroyuki Isayama; Kazuhiko Koike; Kuni Ohtomo
Journal:  Eur Radiol       Date:  2017-06-19       Impact factor: 5.315

3.  Intrapancreatic lipoma and Morgagni hernia: a previously unrecognized association.

Authors:  L Oktay Erdem; C Zuhal Erdem; Mustafa Comert
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

4.  CT differentiation of distal pancreas fat replacement and distal pancreas agenesis.

Authors:  Musturay Karcaaltincaba
Journal:  Surg Radiol Anat       Date:  2006-10-11       Impact factor: 1.246

Review 5.  The clinical significance of pancreatic steatosis.

Authors:  Mark M Smits; Erwin J M van Geenen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-02-08       Impact factor: 46.802

6.  Does the visceral fat tissue show better correlation with the fatty replacement of the pancreas than with BMI?

Authors:  Nilgun Isiksalan Ozbulbul; Mehmet Yurdakul; Muharrem Tola
Journal:  Eurasian J Med       Date:  2010-04

7.  Pancreatitis in the setting of the metabolic syndrome.

Authors:  Gopalakrishna Rajesh; Harish Kumar; Saumya Menon; Vallath Balakrishnan
Journal:  Indian J Gastroenterol       Date:  2012-03-16

8.  Isolated fat-containing pancreatic metastasis from hepatocellular carcinoma.

Authors:  Hideyuki Nishiofuku; Nagaaki Marugami; Toshihiro Tanaka; Hiroshi Anai; Shinsaku Maeda; Tetsuya Masada; Masato Takano; Akira Mitoro; Kimihiko Kichikawa
Journal:  Jpn J Radiol       Date:  2013-03-29       Impact factor: 2.374

9.  Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.

Authors:  N S Patel; M R Peterson; D A Brenner; E Heba; C Sirlin; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2013-02-05       Impact factor: 8.171

10.  Nonalcoholic fatty pancreas disease.

Authors:  Abhishek Mathur; Megan Marine; Debao Lu; Deborah A Swartz-Basile; Romil Saxena; Nicholas J Zyromski; Henry A Pitt
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.